Additionally, patients with impaired liver function often experience chronic inflammation and metabolic disturbances, which not only affect the metabolism of albumin and bilirubin but may also promote muscle breakdown, further exacerbating the development of sarcopenia or myosteatosis (26). Here, ALB is linked to sarcopenia.